Renovaro Inc.

1.45 USD
+0.10 (+7.41%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Renovaro Inc. stock is down -7.64% since 30 days ago. The next earnings date is Sep 30, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 9 July’s closed higher than June.

About Renovaro Inc.

Enochian Biosciences, Inc. engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment.